143 Avsnitt

  1. Immunotherapy rechallenge in NSCLC

    Publicerades: 2022-03-03

  2. ESO’s career development programme

    Publicerades: 2022-02-24

  3. Summary/Review - Reporting Guidelines - CONSORT

    Publicerades: 2022-02-17

  4. Summary/Review: Long-term results of SNB after NCT for primary cN1/2 breast who convert to cN0

    Publicerades: 2022-02-10

  5. Summary/Review: Pathology after neoadjuvant treatment for breast cancer – How to assess residual disease.

    Publicerades: 2022-02-03

  6. Intraoperative breast ultrasound

    Publicerades: 2022-01-27

  7. Summary/Review - Reporting Guidelines - PRISMA 2020

    Publicerades: 2022-01-20

  8. Summary/Review - The use of Artificial Intelligence in the Oncology field. Addressing all the hype and skepticism.

    Publicerades: 2022-01-13

  9. Advanced Gastric Cancer

    Publicerades: 2021-12-09

  10. PARP inhibitors for the treatment of ovarian cancer

    Publicerades: 2021-12-02

  11. The role of clinician-scientists in modern oncology

    Publicerades: 2021-11-25

  12. Pharmacologic interactions with new drugs

    Publicerades: 2021-11-18

  13. Positive Resection Margins in Colon Cancer

    Publicerades: 2021-11-11

  14. Immunotherapy in Lung Cancer

    Publicerades: 2021-11-04

  15. Low HR positive breast cancer

    Publicerades: 2021-10-28

  16. Possibilities of tackling side effects of cancer therapies

    Publicerades: 2021-10-21

  17. Fertility preservation in young cancer patients

    Publicerades: 2021-10-14

  18. CDK4/6i in HR+HER2- breast cancer

    Publicerades: 2021-10-07

  19. Treatment selection in castration-resistant prostate cancer

    Publicerades: 2021-09-30

  20. Questions and Controversies in Localized Head and Neck Cancer

    Publicerades: 2021-09-23

6 / 8

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

Visit the podcast's native language site